Efficacy and safety of oral and vaginal administration of misoprostol for induction of labor in high-risk obese pregnant women with hypertension or diabetes mellitus

References

• Saucedo AM, Cahill AG. Evidence-based approaches to labor induction. Obstet Gynecol Surv. 2023;78(3):1–11. doi:10.1097/OGX.0000000000001110.
   Web of Science ®Google Scholar
• Carlson N, Ellis J, Page K, et al. Review of evidence-based methods for successful labor induction. J Midwifery Womens Health. 2021;66(4):459–469. doi:10.1111/jmwh.13238.
   PubMed Web of Science ®Google Scholar
• Declercq E, Belanoff C, Iverson R. Maternal perceptions of the experience of attempted labor induction and medically elective inductions: analysis of survey results from listening to mothers in California. BMC Pregnancy Childbirth. 2020;20(1):458. doi:10.1186/s12884-020-03137-x.
   PubMed Web of Science ®Google Scholar
• Gissler M, Mohangoo AD, Blondel B, et al. Perinatal health monitoring in Europe: results from the EURO-PERISTAT project. Inform Health Soc Care. 2010;35(2):64–79. doi:10.3109/17538157.2010.492923.
   PubMed Web of Science ®Google Scholar
• Gelber S, Sciscione A. Mechanical methods of cervical ripening and labor induction. Clin Obstet Gynecol. 2006;49(3):642–657. doi:10.1097/00003081-200609000-00022.
   PubMed Web of Science ®Google Scholar
• Wray S, Arrowsmith S, Sharp A. Pharmacological interventions in labor and delivery. Annu Rev Pharmacol Toxicol. 2023;63(1):471–489. doi:10.1146/annurev-pharmtox-051921-122822.
   PubMedGoogle Scholar
• Davis R, Yarker YE, Goa KL. Diclofenac/misoprostol. A review of its pharmacology and therapeutic efficacy in painful inflammatory conditions. Drugs Aging. 1995;7(5):372–393. doi:10.2165/00002512-199507050-00005.
   PubMed Web of Science ®Google Scholar
• Allen R, O’Brien BM. Uses of misoprostol in obstetrics and gynecology. Rev Obstet Gynecol. 2009;2(3):159–168.
   Google Scholar
• Tang OS, Gemzell-Danielsson K, Ho PC. Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects. Int J Gynaecol Obstet. 2007;99(Suppl 2): S160–S167. doi:10.1016/j.ijgo.2007.09.004.
   Google Scholar
• Machado LO, Taquette SR. The use of misoprostol in the termination of pregnancy: a review of studies carried. Cien Saude Colet. 2022;27(8):3079–3090. doi:10.1590/1413-81232022278.03102022.
   Google Scholar
• Aubert J, Bejan-Angoulvant T, Jonville-Bera AP. [Pharmacology of misoprostol (pharmacokinetic data, adverse effects and teratogenic effects)]. J Gynecol Obstet Biol Reprod. 2014;43(2):114–122. doi:10.1016/j.jgyn.2013.11.006.
   PubMedGoogle Scholar
• Kerr RS, Kumar N, Williams MJ, et al. Low-dose oral misoprostol for induction of labour. Cochrane Database Syst Rev. 2021;6(6):CD014484. doi:10.1002/14651858.CD014484.
   PubMedGoogle Scholar
• Rahimi M, Haghighi L, Baradaran HR, et al. Comparison of the effect of oral and vaginal misoprostol on labor induction: updating a systematic review and meta-analysis of interventional studies. Eur J Med Res. 2023;28(1):51. doi:10.1186/s40001-023-01007-8.
   PubMed Web of Science ®Google Scholar
• Pergialiotis V, Panagiotopoulos M, Constantinou T, et al. Efficacy and safety of oral and sublingual versus vaginal misoprostol for induction of labour: a systematic review and meta-analysis. Arch Gynecol Obstet. 2023;308(3):727–775. doi:10.1007/s00404-022-06867-9.
   PubMed Web of Science ®Google Scholar
• Mozurkewich E, Chilimigras J, Koepke E, et al. Indications for induction of labour: a best-evidence review. BJOG. 2009;116(5):626–636. doi:10.1111/j.1471-0528.2008.02065.x.
   PubMed Web of Science ®Google Scholar
• Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American college of cardiology/American heart association task force on practice guidelines and the obesity society. Circulation. 2014;129(25 Suppl 2):S102–S138. doi:10.1161/01.cir.0000437739.71477.ee.
   PubMed Web of Science ®Google Scholar
• Morris JL, Winikoff B, Dabash R, et al. FIGO’s updated recommendations for misoprostol used alone in gynecology and obstetrics. Int J Gynaecol Obstet. 2017;138(3):363–366. doi:10.1002/ijgo.12181.
   PubMed Web of Science ®Google Scholar
• Butwick AJ, Abreo A, Bateman BT, et al. Effect of maternal body mass index on postpartum hemorrhage. Anesthesiology. 2018;128(4):774–783. doi:10.1097/ALN.0000000000002082.
   PubMed Web of Science ®Google Scholar
• Carlson NS, Hernandez TL, Hurt KJ. Parturition dysfunction in obesity: time to target the pathobiology. Reprod Biol Endocrinol. 2015;13:135. doi:10.1186/s12958-015-0129-6.
   PubMed Web of Science ®Google Scholar
• Maged AM, El-Semary AM, Marie HM, et al. Effect of maternal obesity on labor induction in postdate pregnancy. Arch Gynecol Obstet. 2018;298(1):45–50. doi:10.1007/s00404-018-4767-8.
   PubMed Web of Science ®Google Scholar
• Tolcher MC, Holbert MR, Weaver AL, et al. Predicting cesarean delivery after induction of labor among nulliparous women at term. Obstet Gynecol. 2015;126(5):1059–1068. doi:10.1097/AOG.0000000000001083.
   PubMed Web of Science ®Google Scholar
• Stefely E, Warshak CR. Contraction frequency after administration of misoprostol in obese versus non-obese women. J Matern Fetal Neonatal Med. 2019;32(21):3526–3530. doi:10.1080/14767058.2018.1465919.
   PubMed Web of Science ®Google Scholar
• Varlas VN, Bostan G, Nasui BA, et al. Is misoprostol vaginal insert safe for the induction of labor in high-risk pregnancy obese women? Healthcare. 2021;9(4):464. doi:10.3390/healthcare9040464.
   Web of Science ®Google Scholar
• Abbassi RM, Sirichand P, Rizvi S. Safety and efficacy of oral versus vaginal misoprostol use for induction of labour at term. J Coll Physicians Surg Pak. 2008;18(10):625–629. doi:10.2008/JCPSP.625629.
   PubMed Web of Science ®Google Scholar
• Langenegger EJ, Odendaal HJ, Grove D. Oral misoprostol versus intracervical dinoprostone for induction of labor. Int J Gynaecol Obstet. 2005;88(3):242–248. doi:10.1016/j.ijgo.2004.12.005.
   PubMed Web of Science ®Google Scholar
• Prameela, Sharma KD. Comparison between use of oral misoprostol versus vaginal misoprostol for induction of labour at term. J Obstet Gynaecol India. 2018;68(2):88–92. doi:10.1007/s13224-017-0978-3.
   PubMedGoogle Scholar
• Haas DM, Daggy J, Flannery KM, et al. A comparison of vaginal versus buccal misoprostol for cervical ripening in women for labor induction at term (the IMPROVE trial): a triple-masked randomized controlled trial. Am J Obstet Gynecol. 2019;221(3):259 e1–259 e16. doi:10.1016/j.ajog.2019.04.037.
   Web of Science ®Google Scholar
• Mehrotra S, Singh U, Gupta HP. A prospective double blind study using oral versus vaginal misoprostol for labour induction. J Obstet Gynaecol. 2010;30(5):461–464. doi:10.3109/01443615.2010.485253.
   PubMedGoogle Scholar
• Shetty A, Danielian P, Templeton A. A comparison of oral and vaginal misoprostol tablets in induction of labour at term. BJOG. 2001;108(3):238–243. doi:10.1111/j.1471-0528.2001.00073.x.
   PubMedGoogle Scholar
• Nyende L, Towobola OA, Mabina MH. Comparison of vaginal and oral misoprostol, for the induction of labour in women with intra-uterine foetal death. East Afr Med J. 2004;81(4):179–182. doi:10.4314/eamj.v81i4.9151.
   PubMedGoogle Scholar
• Garabedian MJ, Williams CM, Pearce CF, et al. Extreme morbid obesity and labor outcome in nulliparous women at term. Am J Perinatol. 2011;28(9):729–734. doi:10.1055/s-0031-1280852.
   PubMed Web of Science ®Google Scholar
• Wolfe KB, Rossi RA, Warshak CR. The effect of maternal obesity on the rate of failed induction of labor. Am J Obstet Gynecol. 2011;205(2):128 e1–7. doi:10.1016/j.ajog.2011.03.051.
   Web of Science ®Google Scholar